Tonyali, O. Et Al. 2013. Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab. ONKOLOGIE , vol.36, no.10 , 554-558.

Tonyali, O., Coskun, U., Sener, N., İNANÇ, M., Akman, T., Ulas, A., ... Yazilitas, D.(2013). Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab. ONKOLOGIE , vol.36, no.10, 554-558.

Tonyali, Onder Et Al. "Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab," ONKOLOGIE , vol.36, no.10, 554-558, 2013

Tonyali, Onder Et Al. "Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab." ONKOLOGIE , vol.36, no.10, pp.554-558, 2013

Tonyali, O. Et Al. (2013) . "Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab." ONKOLOGIE , vol.36, no.10, pp.554-558.

@article{article, author={Onder Tonyali Et Al. }, title={Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab}, journal={ONKOLOGIE}, year=2013, pages={554-558} }